Publications

Vaccine equity in low and middle income countries: a systematic review and meta-analysis.

Ali, HA; Hartner, A-M; Echeverria-Londono, S; Roth, J; Li, X; ABBAS, K; Portnoy, A; VYNNYCKY, E; Woodruff, K; Ferguson, NM; Toor, J; Gaythorpe, KA;

2022

International Journal for Equity in Health, (2022).21 1 10.1186/s12939-022-01678-5.

"We don't have the same bodies; we don't react the same way": mothers and adolescent girls' perceptions of the risks and benefits of HPV vaccination in France.

KARAFILLAKIS, E; Peretti-Watel, P; Verger, P; CHANTLER, T; LARSON, HJ;

2022

HUMAN VACCINES & IMMUNOTHERAPEUTICS, (2022).18 1 10.1080/21645515.2022.2036555.

Assessing the impacts of timing on the health benefits, cost-effectiveness and relative affordability of COVID-19 vaccination programmes in 27 African Countries.

LIU, Y; PEARSON, CA B; Madriz Montero, A; TORRES-RUEDA, S; Asfaw, E; Uzochukwu, B; Drake, T; Bergren, E; EGGO, R; RUIZ, F; Ndembi, N; Nonvignon, J; JIT, M; VASSALL, A;

2022

medRxiv (2022). 10.1101/2022.05.09.22274846.

Improving Estimates of Social Contact Patterns for Airborne Transmission of Respiratory Pathogens.

MCCREESH, N; Mohlamonyane, M; Edwards, A; Olivier, S; Dikgale, K; Dayi, N; Gareta, D; Wood, R; GRANT, AD; WHITE, RG; Middelkoop, K;

2022

Emerging infectious diseases, (2022).28 10 10.3201/eid2810.212567.

Waning effectiveness of BNT162b2 and ChAdOx1 COVID-19 vaccines over six months since second dose: a cohort study using linked electronic health records.

Horne, EM F; Hulme, W; KEOGH, R; Palmer, T; WILLIAMSON, E; PARKER, EP K; Green, A; Walker, V; Walker, A; Curtis, H; Fisher, L; MacKenna, B; Croker, R; Hopcroft, L; Park, R; Massey, J; Morley, J; Mehrkar, A; Bacon, S; Evans, D; Inglesby, P; Morton, C; Hickman, G; Davy, S; Ward, T; ... Sterne, JA C.

2022

medRxiv (2022). 10.1101/2022.03.23.22272804.

The potential cost-effectiveness of HPV vaccination among girls in Mongolia.

Luvsan, M-E; Vodicka, E; Jugder, U; Tudev, U; CLARK, A; Groman, D; Otgonbayar, D; Demberelsuren, S; LaMongtagne, DS; Pecenka, C;

2022

Vaccine: X, (2022).11, 10.1016/j.jvacx.2022.100161.

Potential impact and cost-effectiveness of injectable next-generation rotavirus vaccines in 137 LMICs: a modelling study.

Debellut, F; Pecenka, C; Hausdorff, WP; CLARK, A;

2022

Human vaccines & immunotherapeutics, (2022).18 1 10.1080/21645515.2022.2040329.

Live-attenuated influenza vaccine effectiveness against hospitalization in children aged 2-6 years, the first three seasons of the childhood influenza vaccination program in England, 2013/14-2015/16.

Boddington, NL; MANGTANI, P; Zhao, H; Verlander, NQ; Ellis, J; Andrews, N; Pebody, RG;

2022

Influenza and Other Respiratory Viruses, (2022).16 5 10.1111/irv.12990.

Importance of ventilation and occupancy to Mycobacterium tuberculosis transmission rates in congregate settings.

Deol, AK; Shaikh, N; Middelkoop, K; Mohlamonyane, M; WHITE, RG; MCCREESH, N;

2022

BMC public health, (2022).22 1 10.1186/s12889-022-14133-5.

Comparative effectiveness of BNT162b2 versus mRNA-1273 boosting in England: a cohort study in OpenSAFELY-TPP.

Hulme, W; Horne, EM F; PARKER, EP K; KEOGH, R; WILLIAMSON, E; Walker, V; Palmer, T; Curtis, H; Walker, A; Mehrkar, A; Morley, J; MacKenna, B; Bacon, SC J; GOLDACRE, B; Hernán, M; Sterne, JA C; The OpenSAFELY collaborative,;

2022

medRxiv (2022). 10.1101/2022.07.29.22278186.